Type I interferon exacerbates Mycobacterium tuberculosis induced human macrophage death

Angela M Lee1,2, Carl F Nathan3,4

  • 1Department of Microbiology & Immunology, Weill Cornell Medicine, New York, NY, 10065, USA.

EMBO Reports
|June 12, 2024
PubMed

Insights

Tuberculosis-infected human macrophages produce type I interferons (IFN-I), triggering cell death. Inhibiting IFN-I signaling reduces gene induction but not macrophage death, suggesting complex mechanisms in TB pathogenesis.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Cell Biology

Background:

  • Type I interferons (IFN-I) are linked to tuberculosis (TB) exacerbation, but the underlying mechanisms remain unclear.
  • Previous studies in mice indicated that IFN-I produced by Mycobacterium tuberculosis (Mtb)-infected macrophages contributes to cell death.

Purpose of the Study:

  • To investigate whether Mtb-infected human monocyte-derived macrophages (MDM) also produce IFN-I and if it contributes to their death.
  • To elucidate the role of IFN-I signaling in the response of human MDM to Mtb infection.

Main Methods:

  • Human MDM were infected with Mtb, and the expression of interferon-stimulated genes (ISGs) was analyzed.
  • Antibodies inhibiting IFN-I signaling were used to assess their impact on ISG induction and MDM death.
  • Quantification of secreted IFN-I and assessment of MDM response to exogenous IFN-I were performed.

Main Results:

  • Mtb-infected human MDM markedly upregulated ISGs, particularly when prepared conventionally.
  • IFN-I signaling inhibition prevented ISG induction but did not reduce Mtb-infected MDM death.
  • Secreted IFN-I was undetectable until late stages, despite early ISG induction.
  • Exogenous IFN-I induced ISG expression and increased MDM death.

Conclusions:

  • Mtb-infected human MDM produce and respond to low levels of IFN-I, contributing to ISG induction and cell death.
  • The observed IFN-I signaling is complex, with only partial susceptibility to neutralizing antibodies.
  • IFN-I likely promotes infected macrophage death in TB patients, potentially involving various cell types.